Did luck help generate a cancer breakthrough? On their latest podcast, the American Council on Science & Health focuses on recent #OHSUResearch identifying a promising molecule for the treatment of triple-negative #BreastCancer. Listen: https://bit.ly/4ja7iOW

This work represents a major milestone in understanding how peroxisomal transporters function at the molecular level. Gupta lab members- @nkhandelwal.bsky.social and , @devinseka.bsky.social made critical contributions that pushed this project forward.

Exciting holiday present for the Gupta lab! 🎉 🎊 Our paper "Molecular mechanism of substrate transport by human peroxisomal ABCD3" is now published in @pnas.org !! 🎉 🎊 lnkd.in/gPaFdEMn. @ohsunews.bsky.social #OHSU #mguptalab #NIHfunded www.mguptalab.com

This season of giving, help us at OHSU do what we do best — provide exceptional health care for those in need in our community — by making a gift today. Your generosity will make the new year bright and ignite hope for patients, health care professionals, students, and more: https://bit.ly/4pU5qMO

Sometimes it's better to be lucky than good 🔬 On their latest podcast, the American Council on Science & Health focuses on recent #OHSUResearch identifying a promising molecule for the treatment of triple-negative #BreastCancer. Listen: https://bit.ly/4ja7iOW

“The FDA approval of ferumoxytol for imaging is an exciting advancement for the field of neuro-oncology because it offers a new approach to imaging assessment, which may lead to improving the quality of life for patients.” - Dr. Ramon Barajas on #OHSUResearch: https://bit.ly/4rW8YPY

📣 Save the Date | Oregon Drug Discovery Symposium (ODDS) 2026 The symposium takes place April 8–9, 2026, and will feature scientific talks, discussions, and a poster session, providing a forum for knowledge exchange across disciplines. Register: https://bit.ly/4qbMRU0

Cancer research is a cornerstone of Oregon’s bioscience sector, generating $11.5B in economic activity in 2023. The PBJ spoke w/ @ohsuknight.bsky.social researchers about what’s needed to sustain innovation & how partnerships can shape a healthier future. #CancerResearch #Bioscience #CommunityImpact

“I’m not going to stop running. I’m going to trust my body and try to put myself in the best position to fight this.” Matt Hazard was determined to race in the Boston Marathon even after learning he was diagnosed with #ColorectalCancer: https://bit.ly/44rKQKZ

The term "recovery friendly workplace" refers to businesses that have taken steps to prevent and respond to substance misuse. Join #OccHealthSci on Jan 15 for a full-day of valuable insights into what it takes to make your workplace recovery friendly. https://loom.ly/AuPakLY

“We’re now identifying many survivors six years out, which is remarkable for a population that had very few options and minimal expectations for any meaningful survival.” - Dr. Richard Maziarz on one of the earliest CAR-T studies #OHSUResearch: https://bit.ly/4oL3BjJ

For Matt Hazard, there may not have been a better decision than listening to his cousin, who urged him to get a colonoscopy. Matt received multidisciplinary care for his #ColorectalCancer diagnosis at OHSU, all while training for the Boston Marathon: https://bit.ly/44rKQKZ

Mark your calendars for April 10, 2026! 🗓️ Join us for the annual OHSU Knight Cancer Symposium in Portland, Oregon. Stay updated on the latest advancements in cancer care, research, and programs. Don't miss this opportunity to learn from experts! Register today: https://bit.ly/4rH8ygm

New CAR-T therapy data 📊 Five-year data from a clinical trial for adults with relapsed or refractory large B-cell lymphoma confirms lasting remissions in high-risk patients, even years after treatment. #OHSUResearch: https://bit.ly/4oL3BjJ

“Health care in this country is facing obstacles like never before. The attack on biomedical research funding is unprecedented.” - @coussenslab.bsky.social on the challenges and opportunities impacting our state’s cancer research ecosystem (via the Portland Business Journal): https://bit.ly/48yHK99

Drs. Lisa Coussens, Shivaani Kummar, and Shannon McWeeney discuss the challenges and opportunities impacting our state’s cancer research ecosystem and what is needed to maintain and accelerate the pace of innovation with the Portland Business Journal. Learn more: https://bit.ly/48yHK99

Chris Eide discussing our new platform that predicts tumor responsiveness and patient outcome for standard-of-care therapies in AML #ASH25 @ohsuknight.bsky.social

Mark your calendars for April 10, 2026! 🗓️ Join us for the annual OHSU Knight Cancer Symposium in Portland, Oregon. Stay updated on the latest advancements in cancer care, research, and programs. Don't miss this opportunity to learn from experts! Register today: https://bit.ly/4rH8ygm

This #GivingTuesday, the OHSU community is uniting to make an impact, and we hope you’ll join us. Begin your season of giving by benefiting life-saving programs, new treatments and cures, and education for tomorrow’s health leaders at OHSU. Donate today: https://bit.ly/493XlNL

In the 80s, Dr. Brian Druker theorized that kinase inhibitors could be transformative for cancer care. Fast forward, and the FDA approved the 100th small-molecule kinase inhibitor, with scientists exploring kinases as potential drug targets. 🔬(@nature.com): https://go.nature.com/43NHQs5

"There are now many exciting technological advancements allowing vast molecular measurements as well as new ways to consider the spatial biology of tumors." - Dr. Laura Heiser on the latest advancements in the understanding of cancer evolution (@theaacr.bsky.social): https://bit.ly/486G9as

In the 80s, Dr. Brian Druker theorized that kinase inhibitors could be transformative for cancer care. Fast forward, and the FDA approved the 100th small-molecule kinase inhibitor, with scientists exploring kinases as potential drug targets. 🔬(@nature.com): https://go.nature.com/43NHQs5

Dr. Laura Heiser discusses the latest advancements in the understanding of cancer evolution and what to expect at the upcoming "Cancer Evolution: The Dynamics of Progression and Persistence" conference. Learn more (via @theaacr.bsky.social): https://bit.ly/486G9as

ICYMI ⤵️ We have received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.

Today, our researchers, clinicians, and staff wore purple in honor of World Pancreatic Cancer Day. Every photo represents hope, solidarity, and the shared commitment that drives our team. Thank you to everyone who wore purple today, helping raise awareness for a disease that urgently needs it. 💜✨

We’re excited to announce that OHSU has received funding through the ACS-Pfizer Addressing Barriers to Cancer Care for American Indian and Alaska Native (AIAN) and Native Hawaiian and Pacific Islander (NHPI) Individuals Grant Program.

“A drug that targets enolase 1 could help improve the treatment of these cancers, too.” - Dr. Sanjay Malhotra, who expects SU212 could be useful in treating other cancers influenced by enolase 1, such as glioma, pancreatic cancer, and thyroid carcinoma: https://bit.ly/480D3pv

Dr. Jennifer Raybin and FNP Kelly Anderson published a study on post-treatment support for survivors. The initiative aimed to break down barriers to specialty care for childhood cancer survivors, which has been met with success: https://bit.ly/47yeyyJ

Without samples of early cancer, it’s hard to understand the changes that occur as healthy tissue becomes cancerous. Tissue engineering is helping close that gap. Recent technologies have enabled scientists to mirror the complexity of cancer in the lab: https://bit.ly/3WC1wew

A new molecule developed by researchers at @OHSUNews offers a promising avenue to treat intractable cases of triple-negative #BreastCancer, which is a form of cancer that is notoriously aggressive and lacks effective treatments. #OHSUResearch: https://bit.ly/480D3pv

Congratulations to Dr. Lisa Coussens on being honored with the 2025 @metastasisresearch.bsky.social's Women in Science Research award for her exceptional, demonstrable contribution to scientific discovery in the field of metastasis research.

Dr. Jennifer Raybin and FNP Kelly Anderson published a study on post-treatment support for childhood cancer survivors. The study details the creation and rollout of a virtual, interdisciplinary survivorship clinic, launched in response to the COVID-19 pandemic. Learn more: https://bit.ly/47yeyyJ

November is Lung Cancer Awareness Month 🤍 Here are 🔟 facts to know about lung cancer.

“These new technologies give us a window into how cancer forms and progresses, which opens the door to understanding early cancer, paving the way for earlier diagnosis and even predicting cancer initiation.” - Dr. Luiz Bertassoni on new #OHSUResearch: https://bit.ly/3WC1wew

“We expected to find some variations in polypectomy technique, but the results were surprising; overall, cold snare usage was lower than expected, given that this is the recommended method for removing most small polyps.” - Dr. Seth Crockett (via @medscape.com): https://wb.md/4o9v5jz

Spooky season success! 🎃👻 The Maxson Lab brought the Halloween flair and festive fun to the office this year! 📸 Dr. Julia Maxson

The Byrne lab's findings suggest that improving CD4+ T cell activation in future immunotherapies will improve outcomes for patients who have historically been resistant to immune-targeting treatments. #OHSUResearch (via @theaacr.bsky.social#OHSUResearch: https://bit.ly/3Jodsxo

A study led by Dr. Seth Crocket finds that fewer than 60% of procedures use the recommended technique for removing colon polyps smaller than 1 cm. #OHSUResearch (via @medscape.com#OHSUResearch: https://wb.md/4o9v5jz

Honored to still be in the fight against cancer. Go get screened!

Using the immune system to fight cancer has revolutionized how scientists treat tumors, but this approach is not effective for all patients. A new study by Dr. Katelyn Byrne and team shines light on an underinvestigated immune cell, the CD4+ T cell (via @theaacr.bsky.social): https://bit.ly/3Jodsxo

Today, @portland-gov.bsky.social observed Breast Cancer Awareness Month by bringing together leaders, professionals, nonprofit partners, and youth advocates to emphasize the importance of early detection, equitable access to care, and community support for everyone facing #BreastCancer.

Drs. Lisa Coussens and David Huang were both recognized at this past weekend's @nam.edu induction ceremony. Both were elected to @nam.edu in 2024 due to their contributions to the fields of cancer research and eye disease diagnosis and care, respectively. 🙌

Fall foliage is in full force on Marquam Hill 🍂🍃🍁

“They knew exactly what to do, and they did it. I was afforded a future because of those wonderful people.” Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received. Learn more about Lisa's story ⤵️

Many thanks @americancancersoc.bsky.social for today’s policy breakfast @ @ohsuknight.bsky.social. Speakers shared powerful insights on advancing cancer research amid historic funding uncertainty. We must ensure that our groundbreaking PNW research continues to improve lives locally & globally.

“They knew exactly what to do, and they did it. I was afforded a future because of those wonderful people.” Lisa Sayer, who received specialized treatment for complex abdominal cancer, is forever grateful for the care she received. Learn more about Lisa's story ⤵️

Join us this fall to raise awareness for #BreastCancer and #LungCancer. Early detection is crucial in the fight against cancer. OHSU is offering breast and lung cancer screenings as part of the Pink and Pearl Campaign on Oct. 17 and Nov. 7. Pre-registration required: https://bit.ly/4edIthO

Last week, Nike celebrated the Portland Marathon and our local community with one of their signature employee events – Thirst Thursday. They welcomed the OHSU Foundation, #DBFreestyle, and other nonprofit partners to help kick off marathon weekend and showcase how employees can volunteer and give.

For the third consecutive year, a new record has been set! 💫 Congrats to our medical team on 14K for registering 366 potential new donors during the 12th annual bone marrow registry drive! The team held five in-person swabbing events, visited classrooms, and distributed their kits throughout town.

“Exercise can still be safe, but it might require more precautions and supervision.” - Dr. Kerri Winters-Stone on whether or not it is safe for men with #ProstateCancer to exercise Learn more (via @everydayhealth.bsky.social):